scispace - formally typeset
A

Avraham Lorber

Researcher at Rambam Health Care Campus

Publications -  158
Citations -  5144

Avraham Lorber is an academic researcher from Rambam Health Care Campus. The author has contributed to research in topics: Patent foramen ovale & Heart failure. The author has an hindex of 37, co-authored 155 publications receiving 4816 citations. Previous affiliations of Avraham Lorber include Sheba Medical Center & Israel Ministry of Health.

Papers
More filters
Journal ArticleDOI

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

TL;DR: A missense mutation in a highly conserved region of the calsequestrin 2 gene (CASQ2) is described as the potential cause of the autosomal recessive form ofatecholamine-induced polymorphic ventricular tachycardia.
Journal ArticleDOI

Error propagation and figures of merit for quantification by solving matrix equations

TL;DR: In this paper, the propagation d'erreur et les autres figures de merite sont definis for chaque composant, si l'on considere la partie du signal orthogonal au spectre des autres composants.
Journal ArticleDOI

Net analyte signal calculation in multivariate calibration

TL;DR: In this paper, the authors used the inverse calibration model to estimate selectivities (ratio of signal available for quantitation to the total measured signal) and found that the selectivities range between 0 and 2% of the measured reflectance signal.
Journal ArticleDOI

Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21

TL;DR: This unique form of autosomal recessive PVT affects young children and may be lethal if left untreated and mapped the disease gene to chromosome 1p13-21.
Journal ArticleDOI

Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation

TL;DR: The results demonstrate that the patient‐specific mutated cardiomyocytes can be used to study the electrophysiological mechanisms underlying CPVT, and investigate catecholamine‐induced arrhythmias in the CASQ2 mutated cells.